Effect of a nutritional supplementation on growth and body composition in short and lean preadolescent boys: A randomised, double-blind, placebo-controlled study.

body composition linear growth nutritional supplementation preadolescents short stature

Journal

Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968

Informations de publication

Date de publication:
Jan 2022
Historique:
revised: 01 08 2021
received: 24 02 2021
accepted: 02 08 2021
pubmed: 5 8 2021
medline: 28 1 2022
entrez: 4 8 2021
Statut: ppublish

Résumé

To evaluate the effect of nutritional supplementation on height, weight and body composition in short and lean male preadolescents. A randomised, double-blinded, placebo-controlled trial of nutritional supplementation of short and lean prepubertal 10-14.5-year-old boys. Primary outcomes included Δheight-SDS and Δweight-SDS. Secondary outcomes included changes in body composition and BMI-SDS. Of 160 boys enrolled, 126 (80%) completed 6 months' intervention. Baseline age, height-SDS, weight-SDS, BMI-SDS, body composition and dietary intake were similar in the formula and placebo groups. 'Good' formula consumers (intake of ≥50% of the recommended dose, n = 30) gained significantly more in weight-SDS, BMI-SDS, fat-free-mass and muscle mass (p < 0.05) than did 'poor' consumers (n = 35) and the placebo group (n = 61). Only in the formula group, positive dose-response correlations were found between consumption of the formula and changes in the outcome parameters examined, including Δheight-SDS (r = 0.301, p = 0.015). Boys aged >11.4 years who were 'good' formula consumers maintained their Δheight-SDS, while Δheight-SDS declined in 'poor' consumers and the placebo group of the same age (p = 0.033). Intervention with a multi-nutrient, protein-rich formula was effective in increasing weight-SDS, fat-free-mass, muscle mass and BMI-SDS in short and lean prepubertal male adolescents. Good consumption of the formula prevented Δheight-SDS decline in the older participants.

Identifiants

pubmed: 34346091
doi: 10.1111/apa.16054
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

141-150

Informations de copyright

©2021 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Références

Spear BA. Adolescent growth and development. J Am Diet Assoc. 2002;102(3):S23-S29.
Cole TJ. Tanner's tempo of growth in adolescence: recent SITAR insights with the Harpenden Growth Study and ALSPAC. Ann Hum Biol. 2020;47(2):181-198.
Hermanussen M. Auxology: an update. Horm Res Paediatr. 2010;74(3):153-164. https://doi.org/10.1159/000317440
Tanner JM. Growth at Adolescence, 2nd ed. Blackwell Scientific Publications; 1962.
Jacob JA, Nair MKC. Protein and micronutrient supplementation in complementing pubertal growth. Indian J Pediatr. 2012;79(1):S84-S91.
Lifshitz F. Nutrition and growth. In: Paige DM, ed. Clinical Nutrition. Nutrition and Growth Supplement 4. C.V. Mosby; 1985. pp. 40-47.
Baron J, Sävendahl L, De Luca F, et al. Short and tall stature: a new paradigm emerges. Nat Rev Endocrinol. 2015;11(12):735-746.
Lebenthal Y, Yackobovitch-Gavan M, Lazar L, et al. Effect of a nutritional supplement on growth in short and lean prepubertal children: a prospective, randomized, double-blind, placebo-controlled study. J Pediatr. 2014;165(6):1190-1193.e1.
Yackobovitch-Gavan M, Lebenthal Y, Lazar L, et al. Effect of nutritional supplementation on growth in short and lean prepubertal children after 1 year of intervention. J Pediatr. 2016;179:154-159.e1.
Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. National Academy Press; 2005.
Roberts JL, Stein AD. The impact of nutritional interventions beyond the first 2 years of life on linear growth: a systematic review and meta-analysis. Adv Nutr. 2017;8(2):323-336.
Lassi ZS, Moin A, Das JK, Salam RA, Bhutta ZA. Systematic review on evidence-based adolescent nutrition interventions. Ann N Y Acad Sci. 2017;1393:34-50.
Campisi S, Carducci B, Söder O, Bhutta Z. The intricate relationship between chronic undernutrition, impaired linear growth and delayed puberty: Is ‘catch-up’ growth possible during adolescence? 2018. Innocenti Working Papers no. 2018-12, UNICEF Office of Research -. Innocenti, Florence.
Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data. 2000;314:1-27.
Tzameret 3 software. Israel center for disease control and the ministry of health. 2016.
IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 25.0. IBM Corp; 2017.
Tanner JM, Davies PS. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr. 1985;107(3):317-329.
Sedlmeyer IL. Palmert MR Delayed puberty: analysis of a large case series from an academic center. J Clin Endocrinol Metab. 2002;87(4):1613-1620.
Solans CV. Lifshitz F Body weight progression and nutritional status of patients with familial short stature with and without constitutional delay in growth. Am J Dis Child. 1992;146:296-302.
Wudy SA, Hagemann S, Dempfle A, et al. Children with idiopathic short stature are poor eaters and have decreased body mass index. Pediatrics. 2005;116(1):e52-57.
Han JC, Balagopal P, Sweeten S, Darmaun D, Mauras N. Evidence for hypermetabolism in boys with constitutional delay of growth and maturation. J Clin Endocrinol Metab. 2006;91(6):2081-2086.
Sarma KVR, Udaykumar P, Balakrishna N, Vijayaraghavan K, Sivakumar BD. Effect of micronutrient supplementation on health and nutritional status of schoolchildren: growth and morbidity. Nutrition. 2006;22(1):S8-S14.
Han JC, Damaso L, Welch S, Balagopal P, Hossain J, Mauras N. Effects of growth hormone and nutritional therapy in boys with constitutional growth delay: a randomized controlled trial. J Pediatr. 2011;158(3):427-432.

Auteurs

Naama Fisch Shvalb (N)

National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, Petah Tikva, Israel.

Liora Lazar (L)

National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, Petah Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Sharon Demol (S)

National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, Petah Tikva, Israel.

Marie Mouler (M)

National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, Petah Tikva, Israel.

Marianna Rachmiel (M)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Pediatric Endocrinology Unit, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.

Eli Hershkovitz (E)

Pediatric Diabetes Unit, Soroka Medical Center, Beer-Sheva affiliated with Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Raanan Shamir (R)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Schneider Children's Medical Center, Institute for Gastroenterology, Nutrition and Liver Diseases, Petach Tikva, Israel.

Moshe Phillip (M)

National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, Petah Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Michal Yackobovitch-Gavan (M)

National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, Petah Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH